Novel CD28 Antagonist mPEG PV1-Fab’ Mitigates Experimental Autoimmune Uveitis by Suppressing CD4+ T Lymphocyte Activation and IFN-γ Production
PLoS ONE - United States
doi 10.1371/journal.pone.0171822
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2017
Authors
Publisher
Public Library of Science (PLoS)